Swiss
biotech Actelion hits record high on
potential Shire bid
LONDON (Reuters) - Shares in
Actelion , Europe's biggest
biotech company, jumped 7 percent to a
record high on Monday after a report
Shire was considering a $18 billion takeover of the
Swiss group...
